White House infectious disease honcho Dr. Anthony Fauci firmly rejected Yale epidemiologist Dr. Harvey Risch’s criticisms of randomized placebo-controlled studies of hydroxychloroquine, siding with ...

Dr. Harvey Risch, an epidemiology professor at Yale School of Public Health, said on Tuesday that he thinks hydroxychloroquine could save 75,000 to 100,000 lives if the drug is widely used to treat ...

Yale School of Public Health professor Harvey Risch has been a vocal supporter of the use of hydroxychloroquine to treat COVID-19, despite a lack of scientific evidence that it works. In a July 23 ...

In 2018, Dr. Harvey Risch was awarded $50,000 for Excellence in Pancreatic Cancer Research. The professor of epidemiology teaches at the Yale School of Medicine, which is consistently recognized as ...

User-Created Clip by robertl9 November 22, 2020 2020-11-19T20:20:09-05:00https://images.c-span.org/Files/0c9/20201119202555002_hd.jpgDr Harvey Risch Testifies about ...

PHILADELPHIA — The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a ...

Answering questions about how countries have responded to COVID-19, Dr. Harvey Risch—a professor of epidemiology at the Yale School of medicine—told Newsweek, "Once the virus became endemic, lockdown ...

A Yale School of Public Health professor who joined the city’s largest police union in a losing fight against a vaccine mandate was slammed last year by colleagues for fringe views on COVID treatments ...

The longer a person takes low-dose aspirin, the lower the risk for pancreatic cancer, according to a study published online June 26 in Cancer Epidemiology, Biomarkers & Prevention. This finding adds ...

The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study recently published. Men and women who took low-dose aspirin regularly had 48 ...